IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Silviya Meletath) · silviya.meletath@utsouthwestern.edu · 214-648-7097

Study leads

Farrukh Awan, MD, MS, MBA
Principal Investigator
University of Texas Southwestern Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin Lymphoma · B-Cell Lymphoma · Relapsed B-cell NHL

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

Mantle Cell Lymphoma · Non Hodgkin Lymphoma · Hematologic Malignancy

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Primary Central Nervous System Lymphoma (PCNSL) · Diffuse Large B Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Primary CNS Lymphoma (PCNSL) · Diffuse Large B Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea